"The 1 mg and 2 mg doses of Ozempic are now available for patients with type 2 diabetes across the U.S.," a Novo Nordisk spokesperson told VERIFY in an email. "However, we are currently experiencing intermittent supply disruptions on the Ozempic pen that delivers 0.25 mg and 0.5 mg doses – which is anticipated through mid-March – due to the combination of incredible demand coupled with overall global supply constraints."